Porter’s Five Forces analysis has been used to determine the attractiveness of global antiemetics market by 2023

Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress, and food poisoning. These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy, and general anesthetics.

Get the Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/435?utm_source=openpr&utm_medium=Niranjan

Global antiemetics market is expected to grow with healthy CAGR during the forecast period due to an increase in the number of patients suffering from cancer and an increased number of surgeries. In-depth discussion of global antiemetics market includes past and current trends with a future forecast up to 2020. Profound assessment of threats and opportunities for new and existing companies running the business in this market would be beneficial to strategist in their respective decision-making process. The report is informative towards geographical segmentation and identifies profitable areas.

Over the few years, antiemetics have witnessed a sudden increase in the sale due to the increasing number of cancer patients. Nausea and vomiting are the common symptoms of chemotherapy and high-risk chemotherapeutic agents include Carmustine and Cisplatin. Additional market drivers include extensive research activities to innovate universal antiemetic drug therapy, use of novel drug delivery to improve patient compliance and identification of new drug targets.

However, the antiemetic drugs, which are in clinical phase requires improvement in clinical trial design for their commercialization. Moreover, a lack of a suitable animal model that will mimic the human responses to antiemetic therapy also restraints the market growth. Novel drug therapies and new drug targets are the opportunities for manufacturers that would help them to increase their market share.

Purchase the report @Discount: https://www.alliedmarketresearch.com/checkout/571684?utm_source=openpr&utm_medium=Niranjan

Global Antiemetics Market by Type:

The antiemetics market is segmented by type of drugs into different categories such as 5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, and Others. 5-HT3 receptor antagonists, Dopamine antagonists, and Cannabinoids are popular categories of antiemetics. Dronabinol is the largest selling drug from Cannabinoids, whereas Domperidone dominates the dopamine antagonists. Ondansetron, Dolasetron, and Palonosetron are the top-selling drugs from 5-HT3 receptor antagonists.

Global Antiemetics Market by Application:

Antiemetics are used to treat the emesis arising from several medical conditions and include Chemotherapy, Motion sickness, Gastroenteritis, general anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, and Others. Chemotherapy leads the application segment as the number of patients suffering from cancer is increasing day by day.

Global Antiemetics Market by Geography:

Geographically, the global antiemetics market is segmented into North America, Europe, Asia-pacific and LAMEA. North America and Europe lead the global antiemetics market due to a high incidence of cancer. Asia-Pacific is the fastest growing market due to the increasing number of cancer population, high incidences of gastroenteritis and other diseases that lead to nausea and vomiting.

Competitive Landscape:

The leading companies in the global antiemetics market include GlaxoSmithCline, Merck, Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Astellas Pharma, Johnson & Johnson, Baxter International, and others. Antiemetics market has witnessed a strong competition due to a large number of companies are trying to focus their R&D efforts to manufacture universal antiemetic therapy, which would offer improved patient compliance. Competitors are also focusing on novel drug deliveries that would show better outcomes as compared to conventional therapies.

High-Level Analysis:

The study identifies the potential market drivers, challenges and trends. Competitive landscape section provides explicit information of the top players ruling the global antiemetics market, their operating strategies, new launches, pipeline therapies, and clinical trials. Porter’s Five Forces analysis has been used to determine the attractiveness of global antiemetics market. Market landscape for antiemetics is varied and contains numerous big and small players. Moreover, demand for antiemetic drugs is high due to an increasing number of cancer population and diseases that lead to nausea and vomiting.

Hence, supplier’s power is moderate for global antiemetics market. Antiemetics are the secondary indication for many of the medical conditions and it fascinates new companies to enter the market. An industrial rivalry is intense due to exhaustive R&D activities and clinical trials to innovate universal antiemetic therapy.

KEY BENEFITS:

This report offers the following benefits in particular:
Comprehensive coverage of global antiemetics market along with disease overview, market trends, drivers and restraints would assist strategist in their respective business decisions. Thorough attention is given to leading company portfolios, pipeline research, new launches and competitive landscape of top players. Explicit information on current clinical trials and R&D activities would be beneficial to understand the future market trends
Insightful analysis of different segments helps to recognize and capitalize future opportunities within global antiemetics market.

KEY DELIVERABLES

The global antiemetic drugs market is segmented into three major categories such as type, application, and geography.

MARKET BY TYPE
- 5-HT3 receptor antagonists
- Dopamine antagonists
- NK1 receptor antagonist
- Antihistamines (H1 histamine receptor antagonists)
- Cannabinoids
- Benzodiazepines
- Anticholinergics
- Steroids
- Others

MARKET BY APPLICATION
- Chemotherapy
- Motion sickness
- Gastroenteritis
- General anesthetics
- Opioid analgesics
- Dizziness
- Pregnancy
- Food poisoning
- Emotional stress
- Others

MARKET BY GEOGRAPHY
- North America
- Europe
- Asia-Pacific
- LAMEA

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.